Martin Shkreli was convicted of three criminal counts but acquitted of five others. He faces possible prison time. » Read More
By: Christina Farr
Andy Page, formerly president of Google-backed 23andMe, is joining Livongo, a chronic disease management start-up, as its president and CFO. » Read More
Drugmaker Hikma's US unit reportedly raised the price of a common diarrhea drug by more than 400 percent. » Read More
By: Bertha Coombs
State health insurance regulators expect that the fate of key health insurance subsidies will remain in limbo past key deadlines next month. » Read More
Shares of EpiPen maker Mylan climbed on the heels of the company reporting fourth-quarter earnings that topped expectations.
The stock slid sharply in morning trading before rebounding to climb about 1 percent higher Wednesday.
The hire signals Carl Icahn may be back, at a time when biotech valuations are 25 percent off their 2015 highs.
President Donald Trump and Republican lawmakers want to increase the tax advantages for accounts that will help you pay for health care.
President Donald Trump urged Democrats to work with Republicans in Congress to replace Obamacare, calling it a "disaster."
Steve Beshear defends the Affordable Care Act in the Democratic response to Trump's address.
As President Donald Trump details how he will change the Affordable Care Act, five patients describe how the law has affected them.
President Trump tells Fox News he plans to use Tuesday night's address to detail ideas on how to fix health care.
Nima is a food-allergen detection device created by MIT graduates to help diners detect dangers on their plates.
The World Health Organization creates the list to spur research for new antibiotics that can counter increasingly resistant bacteria.
Johnson & Johnson said the net increase in the cost of its medicines across its portfolio was 3.5 percent.
The "Fast Money" trader make their case for stocks in the health care sector.
The growth of bacteria in sink drains isn't reassuring when you're expected to wash hands upon entering a hospital, NBC News reports.
A new class of drugs that fight migraines could cost as much as $10,000 a year, NBC News reports.
The death rate from drug overdoses more than doubled between 1999 and 2015, according to a report from the CDC.
Shares of Incyte rose more than 6 percent in Friday trade on news that the pharmaceutical company will join the S&P 500.
Vice President Mike Pence issued a proclamation to the Conservative Political Action Conference Thursday: the "Obamacare nightmare is about to end."
Opposition to the Affordable Care Act has dropped by seven percentage points since early January, before Donald Trump became president.
A Republican push to repeal and replace Obamacare has slowed amid concerns over large numbers of people losing health coverage.
Shkreli is accused of ripping off his former pharma company Retrophin to pay off hedge-fund investors he was accused of defrauding.
Get the best of CNBC in your inbox